Results 91 to 100 of about 568,486 (233)

Effect of Adding Losartan to Bevacizumab for Treating Diabetic Macular Edema

Journal of Ophthalmology, 2020
Introduction. Diabetic retinopathy is the most common cause of visual loss and blindness in the age group of 20 to 64 years. This study aimed to evaluate the efficacy of oral Losartan adjuvant therapy in combination with intravitreal injection of ...
Fariba Ghassemi, Abdulrahim Amini, Masoud Yasemi, Amin Nabavi, Mohammadkarim Johari   +4 more
doaj   +1 more source

Primary treatment of diabetic macular edema

, 2009
Tushar M Ranchod, Stuart L FineScheie Eye Institute, Department, of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USAAbstract: Diabetic macular edema (DME) is a leading cause of vision loss in older Americans.
Stuart L Fine, Tushar M Ranchod
core  

Defining cystoid macular degeneration in diabetic macular edema: An OCT-based single-center study

, 2019
To describe cystoid macular degeneration (CMD), which has no clear definition in diabetic macular edema (DME), and examine its features in optical coherence tomography (OCT) and fundus fluorescein angiography (FFA)
Yalçın, Gökçen, Şengül Özdek, Fatma Nur Baran Aksakal, Baran Aksakal, Fatma Nur, Özdek, Şengül, Yalçın, G., Gökçen Yalçın, Yalcin, Gokcen, Aksakal, F.N.B., Özdek, Ş.   +9 more
core   +1 more source

Topical Interferon Alpha 2b in the Treatment of Refractory Diabetic Macular Edema

Journal of Ophthalmic & Vision Research, 2020
Purpose: To report the efficacy of topical interferon alpha 2b in the treatment of refractory diabetic macular edema. Methods: In this retrospective interventional case series, five eyes of three individuals with diabetic macular edema resistant to
Arash Maleki, Andrew Phillips Stephenson, Fedra Hajizadeh   +2 more
doaj   +1 more source

Diabetic macular edema: it is more than just VEGF [version 1; referees: 2 approved]

F1000Research, 2016
Diabetic macular edema is a serious visual complication of diabetic retinopathy. This article reviews the history of previous and current therapies, including laser therapy, anti-vascular endothelial growth factor agents, and corticosteroids, that have ...
Michael A. Singer, Daniel S. Kermany, Jana Waters, Michael E. Jansen, Lyndon Tyler   +4 more
doaj   +1 more source

The Relationship Between Macular Cyst Formation and Ischemia in Diabetic Macular Edema

, 2019
To evaluate the relationship between cyst characteristics and macular and peripheral ischemia in diabetic macular edema (DME)
Şengül Özdek, Nuriye Gökçen Yalçın, Özdek, Şengül, Yalçın, Nuriye Gökçen   +3 more
core   +1 more source

Diabetic macular edema: Evidence-based management

Indian Journal of Ophthalmology, 2018
Diabetic macular edema (DME) is the most common cause of vision loss in patients with diabetic retinopathy with an increasing prevalence tied to the global epidemic in type 2 diabetes mellitus.
D. Browning, M. W. Stewart, Cho-Ping Lee
semanticscholar   +1 more source

Comparison of vitrectomized with nonvitrectomized eyes after subtenon injection of triamcinolone acetonide to treat diabetic macular edema: Retrospective comparative Analysis of an interventional case series

Indian Journal of Ophthalmology, 2017
Purpose: Triamcinolone acetonide (TA) is an alternative option for diabetic macular edema thanks to its cost-benefit ratio and unique delivery route. We performed this study to compare vitrectomized with nonvitrectomized eyes treated with subtenon TA ...
Kang Yeun Pak, Beom Seok Choi, Sung Who Park, Ik Soo Byon, Ji Eun Lee   +4 more
doaj   +1 more source

Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema.

Journal of Clinical Investigation, 2019
The majority of patients with diabetic macular edema (DME), the most common cause of vision loss in working-age Americans, do not respond adequately to current therapies targeting VEGFA.
Akrit Sodhi, T. Ma, D. Menon, M. Deshpande, Kathleen Jee, Aumreetam Dinabandhu, Jordan Vancel, Daoyuan Lu, S. Montaner   +8 more
semanticscholar   +1 more source

VEGF in Diabetic Retinopathy and Age-Related Macular Degeneration

International Journal of Molecular Sciences
Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis throughout the human body, influencing countless physiological and pathological processes, including tumor growth, preeclampsia, and retinal diseases such as diabetic retinopathy (
Andrew B. Callan, J. Heckman, Giani Tah, Samantha A LopeZ, Laura Valdez, Andrew Tsin   +5 more
semanticscholar   +1 more source